Aqua Medical Secures Series B Funding to Advance U.S. Pivotal Trial for Novel Through-the-Scope Type 2 Diabetes Procedure

Led by Relevance Ventures, the funding will support the completion of Aqua Medical's ongoing U.S. RESTORE-1 pilot study evaluating its investigational PIMA procedure for Type 2 diabetes while funding operational preparations to initiate a p…

Summary from PR Newswire - FDA Approval.

Coverage 1 article · 1 outlet

1. PR Newswire - FDA Approval 12h ago
   Aqua Medical Secures Series B Funding to Advance U.S. Pivotal Trial for Novel Through-the-Scope Type 2 Diabetes Procedure ↗